Related Experiment Video
Updated: Mar 2, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.8K
MO-D-BRB-07: Failure-Mode and Effects Analysis Study for CyberKnife Stereotactic Radiosurgery
S Dieterich1,2,3, E Ford1,2,3, C Halasz1,2,3
1UC Davis, Stanford, CA.
Medical Physics
|May 19, 2017
Summary
This Failure Modes and Effect Analysis (FMEA) for CyberKnife Stereotactic Radiosurgery found most quality assurance (QA) focuses on technical failures, not process or human errors. New QA procedures are recommended to improve patient safety in radiosurgery.
Area of Science:
- Medical Physics
- Radiation Oncology
- Quality Assurance
Background:
- Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) are advanced cancer treatments.
- CyberKnife is a robotic SRS/SBRT delivery system requiring robust quality assurance (QA).
- Existing QA procedures may not adequately address all potential failure modes.
Purpose of the Study:
- To conduct a Failure Modes and Effect Analysis (FMEA) for CyberKnife radiosurgery.
- To evaluate the sensitivity of current QA procedures.
- To identify areas for new QA implementation to enhance patient safety.
Main Methods:
- Interviews with multidisciplinary CyberKnife team members to identify failure modes.
- Development of a patient flow chart to map failure modes.
- Correlation of failure modes with existing QA procedures using a matrix.
Main Results:
- 180 failure modes identified; 85% were process or human errors, 15% technical.
- Significant overlap in failure modes between CyberKnife and Gamma Knife systems.
- Effective QA includes physics second chart review and pre-treatment time-out checklists.
- New checklists, procedure guidelines, and an ARIA-CyberKnife DICOM interface were developed or are being implemented.
Conclusions:
- This is the first FMEA study for CyberKnife SRS.
- The study transitions QA from experience-based technical checks to a comprehensive technical, process, and human safety approach.
- This framework supports medical physicists in delivering safer SRS/SBRT treatments.

